← FDA Drug Approvals (Drugs@FDA)
TRIVARIS
NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2008-06-16
Drug application
- FDA Application #
NDA022220
- Application type
- New Drug Application
- Brand name
- TRIVARIS
- Generic name
- Triamcinolone Acetonide
- Active ingredients
- TRIAMCINOLONE ACETONIDE
- Dosage form
- INJECTABLE
- Route
- INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
- Marketing status
- Discontinued
- Sponsor
- ALLERGAN
- First approval
- 2008-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown